MORE►
Alzheimer’s disease
Photo: UNT Health Fort Worth
The Last Word: UNT Health FW Gets $6.8M for Alzheimer’s Study on Adults With Down Syndrome
by David Seeley | May 28, 2026
Studies show the lifetime incidence of Alzheimer’s disease among adults with Down syndrome is 90%. Researchers called the national ABC-DS study "especially timely" as more treatment options for Alzheimer’s disease are found and more clinical trials are launched for adults with Down syndrome.
by Sandra Engelland |
May 28, 2026
Studies show the lifetime incidence of Alzheimer’s disease among adults with Down syndrome is 90%. Researchers called the national ABC-DS study "especially timely" as more treatment options for Alzheimer’s disease are found and more clinical trials are launched for adults with Down syndrome.
MORE►
by Quincy Preston |
Sep 3, 2025
The new federal Alzheimer's hub joins an elite network of 37 centers nationwide. Scientists from UT Southwestern, UT Arlington, and UT Dallas will decode dementia by exploring hypertension's role, analyzing voice patterns with AI, and creating virtual patient models.
MORE►
by David Seeley |
Mar 18, 2025
"The launch of ZUNVEYL is a game-changer in our fight against Alzheimer’s disease," said Lauren D’Angelo, COO and chief commercial officer at Alpha Cognition. The drug is designed to provide "a differentiated treatment option" for patients with mild-to-moderate Alzheimer’s diagnoses.
MORE►
Dr. Karen Rodrigue (left) and Dr. Kristen Kennedy will use 7-Tesla imaging to measure myelin levels, cortical thickness and neurochemical molecular and cellular brain signatures. [Photo: UTD]
UT Dallas Researchers Get $3.7M NIH Grant To Explore the Aging Brain
by Lance Murray | Nov 5, 2024
UTD psychology professors Karen Rodrigue and Kristen Kennedy will use one of the most powerful imaging machines in existence—the 24-ton 7-Tesla magnetic resonance scanner—to identify the major brain differences between younger and older adults.
MORE►
by Lance Murray |
Jul 29, 2024
“The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer's disease as it's only the second oral AD treatment to be approved in more than a decade," said CEO Michael McFadden of Alpha Cognition. Based in Vancouver with an office in Frisco, the company was honored at the 2023 BioNTX iC3 Summit as one of eight "Rising Stars."
MORE►
by David Seeley |
Dec 13, 2023
Based in Vancouver with a North Texas office in Frisco, Alpha Cognition said its novel oral tablet ALPHA-1062 is designed for the treatment of people with mild to moderate Alzheimer's disease. The company was honored at the recent BioNTX iC3 Summit as one of eight "Rising Stars."
MORE►
by David Seeley |
Apr 17, 2023
Subtle changes in the way people speak could help doctors diagnose cognitive impairment and Alzheimer’s disease—even before symptoms begin to show. That's according to a new study led UT Southwestern researcher Ihab Hajjar, M.D., working with a research team at Emory University in Atlanta. After being given standard cognitive assessments, 206 participants were asked to talk about an art work. Here's what happened next.
MORE►
[Image: PopTika/Shutterstock]
Fort Worth’s Rainwater Charitable Foundation Awards $600K in Prizes for Brain Research
by Lance Murray | Jan 27, 2023
The foundation—launched in the early 1990s by Fort Worth billionaire and philanthropist Richard E. Rainwater—said that this year's $400K Outstanding Innovation Prize will be awarded to a team from the University of California San Diego and Washington University.
Dr. Susanne Wegmann of the German Center for Neurodegenerative Diseases (DZNE) will be awarded the $200K Rainwater Prize for Innovative Early-Career Scientist.
MORE►
by David Seeley |
Jan 18, 2023
Frisco-based pharmacy services provider Soleo Health has been selected by Eisai Inc. as the sole specialty pharmacy distribution partner for Leqembi (lecanemab-irmb), a newly FDA-approved treatment for early and mild stages of Alzheimer’s Disease.
Soleo Health CEO Drew Walk says the partnership "will afford the Alzheimer’s community continued hope while we assist patients and their caregivers as they navigate their healthcare journey."
MORE►
by Kevin Cummings |
Oct 3, 2022
The funding from the National Institutes of Health will help UNT HSC at Fort Worth advance its ongoing research on how Alzheimer's disease affects different racial and ethnic groups. Sid O'Bryant, executive director of UNT HSC's Institute for Translational Research, said there's never been a large-scale study like this before.
“This award and project are nothing short of a bio behavioral ‘moonshot’ program," adds Brian Gladue, HSC executive VP for research and innovation.
MORE►
by Sandra Engelland |
Mar 16, 2021
Contracting Alzheimer's is the No. 1 fear of people over 65, says Sid O'Bryant, who wants to give primary physicians the ability to test for Alzheimer's with a blood test. That can offer peace of mind to many and earlier help for those who need it.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
MORE►
[Photo by Nitro100 via iStock]
R&D: No Pleasure in Life—SMU Scientists Test Treatment; UTSW Studies Hepatitis C & Liver Cancer
by Lance Murray | Jan 25, 2019
You’ll also find out about how research at the University of Texas at Dallas may help determine who is at high risk for Alzheimer’s disease in this roundup of research and development activity in North Texas.
MORE►
![R&D: UTA Professor's Quest to Unify Storm Forecasts; UTSW Studies 'Couch Potato' Behavior Photo: Igor Zhuravlov/iStock]](https://s24806.pcdn.co/wp-content/uploads/2016/09/Verizon-tornado-970-iStock_IgorZhuravlov-360x203.jpg)
by Lance Murray |
Jan 11, 2019
In this roundup of research and development work going on in North Texas, you'll also learn about a $3M gift to the UNT Health Science Center that will fund an endowed chair and benefit Alzheimer's research.
MORE►
by Lance Murray |
Jan 4, 2019
You'll also find out about an SMU physicist who's been named a fellow in a prestigious science group in the roundup of research and development activity in North Texas.
MORE►
by Lance Murray |
Nov 9, 2018
Also, you'll learn about the Dallas-based American Heart Association backing research teams looking into age-related cognitive declines, and a Plano-based biotech company getting an approval from the EPA.
MORE►
